---
id: 068
title: Amphotericin B Toxicity and Management
category: antimicrobials
subcategory: amphotericin_b
tags: [amphotericin-B, nephrotoxicity, infusion-reactions, electrolytes, premedication]
difficulty: hard
---

## Question

What are the major toxicities of amphotericin B and how are they managed? Use the **"AMPHO-TOXIC: K-Mg-RENAL-RIGOR"** mnemonic.

## Answer

### **"AMPHO-TOXIC: K-Mg-RENAL-RIGOR" Mnemonic:**

**K-Mg (Electrolyte Wasting):**
- **K**+ wasting (hypokalemia 50%)
- **Mg**2+ wasting (hypomagnesemia 33%)

**RENAL (Nephrotoxicity):**
- **R**enal tubular acidosis (RTA type 1)
- **E**levated creatinine (30-80% with deoxy)
- **N**ephrotoxicity dose-limiting
- **A**cute tubular necrosis
- **L**iposomal form reduces risk (15-20%)

**RIGOR (Infusion Reactions):**
- **R**igors, chills (73% first dose)
- **I**nfusion-related reactions common
- **G**enerally improve with subsequent doses
- **O**ccur within 1-3 hours of infusion
- **R**espond to premedication

### **Major Toxicities:**

#### **1. Nephrotoxicity (30-80% Deoxycholate, 15-20% Liposomal):**

**Mechanism:**
- Direct renal tubular toxicity
- Renal vasoconstriction (↓ GFR)
- Tubuloglomerular feedback activation

**Clinical Manifestations:**
- **↑ Creatinine** (most common)
- **Hypokalemia** (50% - renal K+ wasting)
- **Hypomagnesemia** (33% - renal Mg2+ wasting)
- **Renal tubular acidosis** (Type 1, distal RTA)
- **Impaired urinary concentrating ability**

**Risk Factors:**
- Deoxycholate formulation (vs liposomal)
- Cumulative dose
- Concurrent nephrotoxins (vancomycin, aminoglycosides, NSAIDs)
- Baseline renal impairment
- Volume depletion

#### **2. Infusion-Related Reactions (73% First Dose):**

**Symptoms:**
- **Fever, chills, rigors** (most common)
- **Headache**
- **Nausea, vomiting**
- **Hypotension** (rare)
- **Tachypnea**

**Timing:** Within 1-3 hours of starting infusion

**Pattern:** Usually **improves with subsequent doses** (tachyphylaxis)

## Key Points

### **Prevention and Management of Toxicity:**

#### **Nephrotoxicity Prevention:**

| Strategy | Implementation | Efficacy |
|----------|----------------|----------|
| **Use liposomal formulation** | L-AmB instead of deoxycholate | ↓ Nephrotoxicity 30-80% → 15-20% |
| **Saline preloading** | 1L NS before infusion | Modest benefit |
| **Avoid concurrent nephrotoxins** | Stop NSAIDs, minimize vanc/aminoglycosides | Important |
| **Monitor electrolytes** | Daily initially, then weekly | Catch early |

#### **Electrolyte Monitoring and Replacement:**

**Monitoring Schedule:**
- **Daily** electrolytes until dose stabilized
- **Weekly** thereafter during therapy
- Check: **K+, Mg2+, Cr, BUN**

**Replacement:**
- **Hypokalemia:** Aggressive K+ repletion (often requires **40-100 mEq/day**)
- **Hypomagnesemia:** Mg2+ repletion (2-4g IV daily may be needed)
- **Both often refractory** until ampho B stopped

**Pearl:** K+ and Mg2+ wasting **continues throughout therapy** - requires ongoing aggressive replacement

#### **Infusion Reaction Management:**

**Premedication (If Reactions Occur):**

| Medication | Dose | Timing | Indication |
|------------|------|--------|------------|
| **Acetaminophen** | 650mg PO | 30-60 min before | Fever, headache |
| **Diphenhydramine** | 25-50mg IV/PO | 30-60 min before | General reactions |
| **Hydrocortisone** | 25-50mg IV | Before infusion | Severe reactions |
| **Meperidine** | 25-50mg IV | During rigors | **Rigors** (most effective) |

**Important:** **Routine premedication NOT recommended** - only use if reactions occur

**Other Strategies:**
- **Slow infusion rate** (infuse over 4-6 hours)
- **Reduce dose temporarily**
- Consider liposomal formulation (fewer infusion reactions)

### **Formulation Comparison - Toxicity:**

| Toxicity | Deoxycholate | Liposomal (L-AmB) |
|----------|--------------|-------------------|
| **Nephrotoxicity** | 30-80% | **15-20%** ✅ |
| **Infusion reactions** | Very common (73%) | **Less common** ✅ |
| **K+/Mg2+ wasting** | Common | **Less common** ✅ |
| **Cost** | Cheap ($) | **Very expensive** ($$$) |

### **When to Stop or Reduce Dose:**

**Discontinue if:**
- Cr doubles from baseline
- Severe, persistent infusion reactions despite premedication
- Alternative antifungal available

**Dose Reduction Strategies:**
- Switch to liposomal formulation
- Alternate-day dosing (controversial)
- Lower dose if clinically improving

### **Clinical Pearls:**
- **Liposomal formulation** dramatically reduces all toxicities
- **K+ and Mg2+ wasting** require aggressive, ongoing replacement (not one-time)
- **Premedicate ONLY if reactions occur** (not routinely)
- **Meperidine most effective** for rigors/chills
- **Saline preloading** (1L NS) may reduce nephrotoxicity
- **Infusion reactions improve** with subsequent doses (tachyphylaxis)
- **Monitor electrolytes closely** - hypokalemia can cause arrhythmias
- Nephrotoxicity usually **reversible** after stopping (though may take weeks)

## Sources

- [StatPearls NBK482327: Amphotericin B]
- [Clinical Therapeutics 2021: Amphotericin Infusion-Related Reactions Review]
- [PMC5119430: Amphotericin Nephrotoxicity Frequency and Factors]
- [PMC6369474: Renal Recovery from L-AmB Nephrotoxicity]

## Media

N/A
